← Back to all trials
Recruiting
NCT07417969
"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"
Conditions: Urine Output Decreased
Sex: All
Ages: 18 Years – 100 Years
Healthy volunteers: No
Phase: NA
Enrollment: 56
Sponsor: Jose J Zaragoza, MD MSc
Location: 76000 Querétaro City Querétaro
Summary
This study aims to compare the effectiveness of furosemide alone versus the combination of furosemide plus albumin in critically ill adult patients with fluid overload. The trial evaluates whether co-administration of albumin enhances diuretic response compared with standard furosemide therapy. The primary outcomes include urine output at 2 hours, changes in renal perfusion markers, and biochemical parameters. Secondary outcomes include changes in mean arterial pressure, electrolyte balance, and renal resistance index. The study seeks to determine whether adding albumin provides a clinically meaningful improvement in diuresis and renal function compared with furosemide monotherapy.
Eligibility Criteria
Inclusion Criteria:
* Adults ≥18 years
* Critically ill patients admitted to the intensive care unit (ICU)
* Presence of oliguria defined as urine output \
Source: ClinicalTrials.gov (NCT07417969). StuddyBuddy aggregates publicly available trial information.